The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients
Endologix
450 participants
Oct 6, 2023
OBSERVATIONAL
Conditions
Summary
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
Eligibility
Inclusion Criteria1
- \-
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Percutaneous Transmural Arterial Bypass Therapy using the DETOUR™ System
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06315023